Adage Capital Partners’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.6M | Hold |
4,881,125
| – | – | 0.05% | 346 |
|
|
2025
Q1 | $28.6M | Hold |
4,881,125
| – | – | 0.05% | 337 |
|
|
2024
Q4 | $40.1M | Hold |
4,881,125
| – | – | 0.07% | 264 |
|
|
2024
Q3 | $43.5M | Sell |
4,881,125
-3,875
| -0.1% | -$34.5K | 0.08% | 256 |
|
|
2024
Q2 | $36.9M | Buy |
4,885,000
+420,000
| +9% | +$3.18M | 0.07% | 282 |
|
|
2024
Q1 | $35.1M | Buy |
4,465,000
+240,000
| +6% | +$1.88M | 0.07% | 313 |
|
|
2023
Q4 | $37.4M | Buy |
4,225,000
+1,350,000
| +47% | +$12M | 0.08% | 258 |
|
|
2023
Q3 | $25.8M | Buy |
2,875,000
+165,000
| +6% | +$1.48M | 0.06% | 325 |
|
|
2023
Q2 | $33.5M | Hold |
2,710,000
| – | – | 0.07% | 270 |
|
|
2023
Q1 | $25.1M | Buy |
2,710,000
+577,261
| +27% | +$5.36M | 0.06% | 360 |
|
|
2022
Q4 | $22.4M | Buy |
2,132,739
+681,538
| +47% | +$7.16M | 0.05% | 392 |
|
|
2022
Q3 | $26.3M | Buy |
1,451,201
+174,582
| +14% | +$3.16M | 0.07% | 331 |
|
|
2022
Q2 | $18.1M | Sell |
1,276,619
-20,400
| -2% | -$289K | 0.04% | 458 |
|
|
2022
Q1 | $28.5M | Buy |
1,297,019
+41,539
| +3% | +$914K | 0.05% | 351 |
|
|
2021
Q4 | $21.3M | Buy |
+1,255,480
| New | +$21.3M | 0.04% | 443 |
|